Listing of the Danish Biotech/Pharma Company, Curasight A/S, on Spotlight Stock Market Exchange

Co-Head of Corporate M&A and Head of Capital Markets, Partner Sam Jalaei, leading the rest of the Magnusson Denmark team consisting of Andreas Hammer, Søren Theilgaard, Tom Froberg, Annelise Lykke and Casper Simonsen,  assisted Spotlight Stock Market, the successful Nordic Stock Exchange for growth companies, with conducting full legal due diligence of Curasight and the related listing and capital markets issues.

Oskar Wollert, Head of Listing at Spotlight Stock Market, states: “Sam and his team conducted a full red flag legal due diligence of Curasight in a timely, skilled and professional manner identifying and spotting the main key issues and providing constructive and operational solutions to them in order to move the process successfully forward towards listing. The Magnusson Denmark team showed true dedication and are valuable partners to us.”